We provide you with 20 years of free, institutional-grade data for ALBO stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of ALBO. Explore the full financial landscape of ALBO stock.
Total insider purchase within 3 month on this page: $0
Total insider selling within 3 month on this page: -$0
Name | Action | Shares | Avg Price | Amount | Reported Date |
---|---|---|---|---|---|
Stephenson Pamela | Grant, award...etc | 55,000 | 2023-01-27 | ||
STRECK PAUL | Grant, award...etc | 55,000 | 2023-01-27 | ||
Harford Simon N.R. | Grant, award...etc | 55,000 | 2023-01-27 | ||
Cooper Ronald Harold Wilfred | Grant, award...etc | 195,000 | 2023-01-27 | ||
Duncan Jason | Grant, award...etc | 55,000 | 2023-01-27 | ||
Mattsson Jan | Grant, award...etc | 55,000 | 2023-01-27 | ||
Carter Martha J. | Grant, award...etc | 55,000 | 2023-01-27 | ||
Graham Michelle | Grant, award...etc | 32,000 | 2023-01-27 | ||
Mattsson Jan | Grant, award...etc | 55,000 | 2023-01-25 | ||
Duncan Jason | Grant, award...etc | 55,000 | 2023-01-25 | ||
Carter Martha J. | Grant, award...etc | 55,000 | 2023-01-25 | ||
Graham Michelle | Grant, award...etc | 32,000 | 2023-01-25 | ||
Harford Simon N.R. | Grant, award...etc | 55,000 | 2023-01-25 | ||
Stephenson Pamela | Grant, award...etc | 55,000 | 2023-01-25 | ||
STRECK PAUL | Grant, award...etc | 55,000 | 2023-01-25 | ||
Cooper Ronald Harold Wilfred | Grant, award...etc | 195,000 | 2023-01-25 | ||
Stephenson Pamela | Sale | -102 | $43.8 | $4,468 | 2023-01-23 |
Duncan Jason | Sale | -228 | $43.8 | $9,986 | 2023-01-23 |
Graham Michelle | Sale | -102 | $43.8 | $4,468 | 2023-01-23 |
Harford Simon N.R. | Sale | -102 | $43.8 | $4,468 | 2023-01-23 |
Mattsson Jan | Sale | -197 | $43.8 | $8,629 | 2023-01-23 |
Cooper Ronald Harold Wilfred | Sale | -1,057 | $43.8 | $46,297 | 2023-01-23 |
Carter Martha J. | Sale | -120 | $43.8 | $5,256 | 2023-01-23 |
Mattsson Jan | Sale | -3,088 | $43.8 | $135,254 | 2023-01-20 |
Harford Simon N.R. | Sale | -1,776 | $43.8 | $77,789 | 2023-01-20 |
Graham Michelle | Sale | -1,774 | $43.9 | $77,886 | 2023-01-20 |
Stephenson Pamela | Sale | -1,774 | $43.9 | $77,886 | 2023-01-20 |
Duncan Jason | Sale | -938 | $43.9 | $41,182 | 2023-01-20 |
Carter Martha J. | Sale | -938 | $43.9 | $41,182 | 2023-01-20 |
Stephenson Pamela | Sale | -575 | $19.06 | $10,960 | 2023-01-09 |
Cooper Ronald Harold Wilfred | Sale | -919 | $19.58 | $17,991 | 2023-01-09 |
Stephenson Pamela | Sale | -469 | $19.06 | $8,940 | 2022-12-27 |
STRECK PAUL | Grant, award...etc | 63,966 | 2022-12-21 | ||
Hopkinson Craig C. | Grant, award...etc | 10,495 | 2022-12-05 | ||
Duncan Jason | Sale | -656 | $19.58 | $12,842 | 2022-10-25 |
Mattsson Jan | Sale | -202 | $19.58 | $3,954 | 2022-10-25 |
Graham Michelle | Sale | -104 | $19.58 | $2,036 | 2022-10-25 |
Harford Simon N.R. | Sale | -104 | $19.58 | $2,036 | 2022-10-25 |
Carter Martha J. | Sale | -104 | $19.58 | $2,036 | 2022-10-25 |
Cooper Ronald Harold Wilfred | Sale | -919 | $19.58 | $17,991 | 2022-10-25 |
Stephenson Pamela | Sale | -104 | $19.58 | $2,036 | 2022-10-25 |
PERCEPTIVE ADVISORS LLC | Sale | -420,416 | $23.23 | $9,766,264 | 2022-10-13 |
Harford Simon N.R. | Sale | -80 | $23.79 | $1,903 | 2022-10-13 |
Stephenson Pamela | Sale | -445 | $19.4 | $8,635 | 2022-09-27 |
Mattsson Jan | Sale | -205 | $24.68 | $5,058 | 2022-07-25 |
Carter Martha J. | Sale | -106 | $24.68 | $2,616 | 2022-07-25 |
Graham Michelle | Sale | -106 | $24.67 | $2,615 | 2022-07-25 |
Harford Simon N.R. | Sale | -106 | $24.67 | $2,615 | 2022-07-25 |
Duncan Jason | Sale | -657 | $24.68 | $16,213 | 2022-07-25 |
Stephenson Pamela | Sale | -106 | $24.67 | $2,615 | 2022-07-25 |
Cooper Ronald Harold Wilfred | Sale | -929 | $24.67 | $22,923 | 2022-07-25 |
Harford Simon N.R. | Sale | -95 | $24.03 | $2,283 | 2022-07-13 |
Stephenson Pamela | Sale | -461 | $19.47 | $8,976 | 2022-06-28 |
Carter Martha J. | Sale | -103 | $32.92 | $3,391 | 2022-04-25 |
Graham Michelle | Sale | -103 | $32.92 | $3,391 | 2022-04-25 |
Cooper Ronald Harold Wilfred | Sale | -907 | $33.11 | $30,031 | 2022-04-25 |
Harford Simon N.R. | Sale | -103 | $32.92 | $3,391 | 2022-04-25 |
Mattsson Jan | Sale | -200 | $32.92 | $6,585 | 2022-04-25 |
Duncan Jason | Sale | -655 | $33.07 | $21,661 | 2022-04-25 |
Stephenson Pamela | Sale | -103 | $32.92 | $3,391 | 2022-04-25 |
Harford Simon N.R. | Sale | -96 | $35.74 | $3,431 | 2022-04-11 |
Stephenson Pamela | Sale | -454 | $30.52 | $13,858 | 2022-03-29 |
Duncan Jason | Sale | -1,688 | $24.88 | $42,001 | 2022-01-25 |
Harford Simon N.R. | Sale | -416 | $24.88 | $10,351 | 2022-01-25 |
Mattsson Jan | Sale | -808 | $24.88 | $20,105 | 2022-01-25 |
Carter Martha J. | Sale | -423 | $24.52 | $10,370 | 2022-01-25 |
Stephenson Pamela | Sale | -416 | $24.88 | $10,351 | 2022-01-25 |
Cooper Ronald Harold Wilfred | Sale | -3,684 | $24.88 | $91,666 | 2022-01-25 |
Graham Michelle | Sale | -418 | $24.72 | $10,334 | 2022-01-25 |
Mattsson Jan | Grant, award...etc | 21,600 | 2022-01-20 | ||
Carter Martha J. | Grant, award...etc | 10,800 | 2022-01-20 | ||
Graham Michelle | Grant, award...etc | 21,600 | 2022-01-20 | ||
Harford Simon N.R. | Grant, award...etc | 21,600 | 2022-01-20 | ||
Duncan Jason | Grant, award...etc | 10,800 | 2022-01-20 | ||
Stephenson Pamela | Grant, award...etc | 21,600 | 2022-01-20 | ||
Harford Simon N.R. | Sale | -111 | $25.95 | $2,880 | 2022-01-11 |
Stephenson Pamela | Sale | -474 | $23.92 | $11,339 | 2021-12-27 |
Horn Patrick Taylor | Sale | -95 | $28.83 | $2,739 | 2021-10-25 |
Duncan Jason | Sale | -312 | $28.85 | $9,001 | 2021-10-25 |
Harford Simon N.R. | Sale | -93 | $30.23 | $2,812 | 2021-10-12 |
Stephenson Pamela | Sale | -451 | $32.05 | $14,456 | 2021-09-28 |
Cooper Ronald Harold Wilfred | Sale | -7,760 | $29.61 | $229,774 | 2021-09-20 |
Cooper Ronald Harold Wilfred | Derivatives Exercise | 11,973 | 2021-09-20 | ||
Duncan Jason | Sale | -313 | $34.13 | $10,683 | 2021-07-26 |
Horn Patrick Taylor | Sale | -90 | $34.13 | $3,072 | 2021-07-26 |
Harford Simon N.R. | Sale | -98 | $35.02 | $3,432 | 2021-07-15 |
The information provided in this report about ALBO stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Albireo Pharma, Inc(NASDAQ:ALBO)

Albireo Pharma, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. Its lead product candidate is odevixibat, an ileal bile acid transpor...
Website: http://www.albireopharma.com
Full Time Employees: 90 (May 2021)
Sector: Healthcare
Industry: Biotechnology